23 May 2013
Keywords: australian, drug, hiv, hepatitis, alzheimer, disease, received
Article | 01 February 1993
Australian drug R&D in HIV, hepatitis B and C and Alzheimer's disease
has received extra funding from a $A21 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com